A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
Abstract Health technology assessment (HTA) can be used to make healthcare systems more equitable and efficient. Advances in precision oncology are challenging conventional thinking about HTA. Precision oncology advances are rapid, involve small patient groups, and are frequently evaluated without a...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-10-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-022-00316-1 |